Moderna Snags $50 Million Ebola Vax Contract

Moderna Snags $50 Million Ebola Vax Contract Moderna is receiving up to $50 million to accelerate the development of an Ebola vaccine, as the virus continues to spread in the eastern Democratic Republic of Congo. The funding is coming from global health organization ​CEPI, which told Reuters that it was possible to bring the vaccines to trial phase within a couple of months.  CEPI said it would also invest up to $8.6 million for a shot developed by the University of Oxford and...